Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Haemonetics Corp (HAE)

Haemonetics Corp (HAE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Haemonetics Corp 125 Summer Street Boston MA 02110 USA

P: 781-848-7100

Description:

Haemonetics Corporation is a Global Leader in Blood Management Solutions. Their comprehensive portfolio of devices, information management, consulting services offers blood management solutions for each facet of the blood supply chain from plasma blood collectors to hospitals. They believe that through proper blood management, their portfolio of products and services helps to prevent a transfusion for the patient who doesn't need one and provides the right blood product, at the right time, in the right dose to the right patient who does.

Key Statistics

Overview:

Market Capitalization, $K 4,233,367
Shares Outstanding, K 50,699
Annual Sales, $ 988,480 K
Annual Net Income, $ 76,530 K
Last Quarter Sales, $ 195,580 K
Last Quarter Net Income, $ 10,530 K
60-Month Beta 0.60
% of Insider Shareholders 1.63%
% of Institutional Shareholders 96.33%
Float, K 49,873
% Float 98.37%

Growth:

1-Year Return -31.70%
3-Year Return 93.09%
5-Year Return 153.93%
5-Year Revenue Growth 8.58%
5-Year Earnings Growth 78.92%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.46 on 08/04/20
Next Earnings Date 11/06/20
Earnings Per Share ttm 2.96
EPS Growth vs. Prev Qtr -33.33%
EPS Growth vs. Prev Year -43.21%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00
Most Recent Split 2-1 on 12/03/12

HAE Ratios

Ratio
Price/Earnings ttm 28.55
Price/Earnings forward 49.28
Price/Earnings to Growth 3.50
Return-on-Equity % 25.98%
Return-on-Assets % 11.93%
Profit Margin % 7.74
Net Margin % 11.55
Debt/Equity 0.52
Price/Sales 4.33
Price/Cash Flow 15.09
Price/Book 6.98
Book Value/Share 12.10
Interest Coverage 6.38
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar